Target intelligence / Profile preview

Biological membrane lipid bilayer (Lipid bilayer)

Target
Lipid bilayer
Molecular classification
Other, Lipid assembly, Structural component
01

Overview

The biological membrane lipid bilayer is a fundamental structural component of all living cells, consisting of two layers of amphipathic phospholipids arranged tail-to-tail (Alberts et al., 2014). It serves as a semi-permeable barrier that separates the internal cellular environment from the external surroundings, facilitating compartmentalization and maintaining ion gradients essential for life (Van Meer et al., 2008). Beyond its structural role, the lipid bilayer acts as a dynamic platform for signal transduction, protein anchoring, and membrane trafficking (Simons & Gerl, 2010). In pharmacology, the lipid bilayer is a critical therapeutic target, particularly for antimicrobial and antifungal agents that exploit differences in lipid composition between pathogens and host cells (Zasloff, 2002). For instance, drugs like daptomycin and polymyxins disrupt bacterial membrane integrity, while polyene antifungals like amphotericin B target sterols within the bilayer to induce pore formation (Baginski & Tugnoli, 2012). General anesthetics are also thought to interact with the lipid bilayer, potentially altering its physical properties to influence the function of embedded membrane proteins (Sonnleitner et al., 2002). However, targeting the lipid bilayer presents significant safety challenges due to the potential for cross-reactivity with human cell membranes, often leading to dose-limiting toxicities such as nephrotoxicity (Velkov et al., 2013). Research into membrane-active agents continues to focus on increasing selectivity for specific lipid species, such as phosphatidylglycerol in bacteria or ergosterol in fungi, to minimize host damage (Mouritsen, 2011).

Other names
Cell membranePlasma membranePhospholipid bilayerCytoplasmic membrane
02

Mechanism of action

Membrane permeabilization, pore formation, depolarization, and disruption of lipid packing (Zasloff, 2002; Baginski & Tugnoli, 2012).

03

Biological functions

Signal transductionBarrier functionCompartmentalizationIon homeostasisCell-cell recognitionOther
04

Disease associations

InfectionCancerNeurodegenerative diseaseOther
05

Safety considerations

Off-target toxicity to host membranesNephrotoxicityNeurotoxicityHemolysisNarrow therapeutic index
06

Interacting drugs

Daptomycin

6 more in the full profile.

07

Biomarkers

Lipidomic signaturesMembrane potentialLactate dehydrogenase release

Beyond the preview

Go deeper on Biological membrane lipid bilayer (Lipid bilayer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological membrane lipid bilayer (Lipid bilayer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call